What Are the Uses of Mupirocin Cream?
Mupirocin ointment, the indication is a topical antibiotic for topical application, suitable for skin infections caused by Gram-positive cocci, such as primary skin infections such as impetigo, edema, folliculitis and co-infection with eczema, ulcers Secondary skin infections, such as co-infection and trauma-infection.
- Drug Name
- Mupirocin ointment
- Drug type
- OTC class A, external medicine, medicine for medical injury
- Use classification
- Other antimicrobials
- Mupirocin ointment, the indication is a topical antibiotic for topical application, suitable for skin infections caused by Gram-positive cocci, such as primary skin infections such as impetigo, edema, folliculitis and co-infection with eczema, ulcers Secondary skin infections, such as co-infection and trauma-infection.
Mupirocin ointment ingredients
- This product contains 20 mg of mupirocin as the main ingredient. Excipients are: polyethylene glycol 400 and polyethylene glycol 3350.
Mupirocin Ointment Properties
- This product is an off-white hydrophilic ointment.
Mupirocin Ointment Action Category
- This product is a non-prescription drug for dermatology.
Mupirocin ointment indications
- This product is a topical antibiotic for skin infections caused by Gram-positive cocci, such as primary skin infections such as impetigo, edema, folliculitis, and secondary infections such as eczema, ulcers, and wounds Skin infections.
Mupirocin Ointment Specifications
- 2%
Mupirocin Ointment Usage and Dosage
- This product should be used topically and applied topically to the affected area. If necessary, the affected area can be wrapped or covered with dressings 3 times a day for a course of 5 days. Repeat as necessary.
Adverse effects of mupirocin ointment
- Topical application This product generally has no adverse reactions, occasionally local burning, tingling and itching. Generally do not need to stop. Occasional skin allergic reactions to mupirocin or its ointment base. Mupirocin ointment has been reported to cause systemic allergic reactions, but it is very rare.
Mupirocin Ointment Taboo
- Allergies to mupirocin or other polyethylene glycol-containing ointments are contraindicated.
Precautions for mupirocin ointment
- 1. If the symptoms do not improve or worsen after one course of treatment, you should go to the hospital immediately.
2. Those with larger infection area should go to the hospital for treatment.
3. This product is for skin administration only. Do not use it on eyes, nose, mouth, etc.
4. Rinse with water when it gets into your eyes by mistake.
5. Use with caution in patients with moderate or severe renal impairment.
6. Pregnant women should be used with caution; breastfeeding women should prevent the drug from getting into the eyes of the baby. If using on the nipple area, wash thoroughly before breastfeeding.
7. For those who are allergic to this product, it is forbidden, and those with allergies should be used with caution.
8. It is forbidden to use this product when its properties are changed.
9. Keep this product out of the reach of children.
10. Children must use under adult supervision.
11. If you are using other medicines, please consult your physician or pharmacist before using this product.
Mupirocin Ointment Drug Interactions
- If a drug interaction may occur with concurrent use of other drugs, consult your physician or pharmacist for details.
Pharmacological effects of mupirocin ointment
- This product has strong antibacterial activity against various Gram-positive cocci related to skin infections, and is also effective against drug-resistant Staphylococcus aureus. It has certain antibacterial effect on some Gram-negative bacteria. No cross-resistance with other antibiotics.
Mupirocin Ointment Storage
- Store below 25 ° C. Sealed.
Mupirocin Ointment Packaging
- Packed in aluminum tube. 5 g each, 1 per box (the cap can be inserted upside down when unsealing to pierce the seal).
Mupirocin ointment expiration date
- 24 months
Mupirocin ointment implementation standards
- Bureau-promulgated standard WS 1- (X-114) -2000Z (see Volume 23 of the Standard for New Drug Conversion) [1]